Liyan Xue

1.4k total citations
50 papers, 922 citations indexed

About

Liyan Xue is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Liyan Xue has authored 50 papers receiving a total of 922 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 23 papers in Surgery and 17 papers in Molecular Biology. Recurrent topics in Liyan Xue's work include Esophageal Cancer Research and Treatment (16 papers), Gastric Cancer Management and Outcomes (8 papers) and Lung Cancer Treatments and Mutations (6 papers). Liyan Xue is often cited by papers focused on Esophageal Cancer Research and Treatment (16 papers), Gastric Cancer Management and Outcomes (8 papers) and Lung Cancer Treatments and Mutations (6 papers). Liyan Xue collaborates with scholars based in China, United States and United Kingdom. Liyan Xue's co-authors include Qimin Zhan, Ning Lü, Xueying Mao, Daniel M. Berney, Yong‐Jie Lu, Yongmei Song, Sakunthala C. Kudahetti, Tracy Chaplin, Bryan D. Young and R.T.D. Oliver and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Liyan Xue

48 papers receiving 912 citations

Peers

Countries citing papers authored by Liyan Xue

Since Specialization

Citations

This map shows the geographic impact of Liyan Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liyan Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liyan Xue more than expected).

Fields of papers citing papers by Liyan Xue

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liyan Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liyan Xue. The network helps show where Liyan Xue may publish in the future.

Co-authorship network of co-authors of Liyan Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Liyan Xue. A scholar is included among the top collaborators of Liyan Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liyan Xue. Liyan Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Incidence of MSI-H esophageal carcinoma and related identification of genomic alterations: A multi-center real-world study 2025 ·Human Pathology ·(unknown), (unknown), Xinqi Yang, (unknown), (unknown), Yi Hu, Jie Yu, Qi Sun, Yunzhao Chen, Liyan Xue, Xiaobin Cui	0
2	Pulmonary Subsolid Nodules 2025 ·CHEST Journal ·Fenglan Li, (unknown), Changfa Xia, Jianing Liu, (unknown), (unknown), Liyan Xue, Shangli Cheng, Jiang Xu, Jianwei Wang	1
3	Prognostic significance of lymphovascular invasion in patients with pT1b esophageal squamous cell carcinoma 2023 ·BMC Cancer ·(unknown), Hua Lin, (unknown), Yong Liu, (unknown), (unknown), Bingzhi Wang, Liyan Xue	4
4	Primary pulmonary hyalinizing clear cell carcinoma with vocal-cord squamous cell carcinoma: a case report with systematic review 2023 ·Diagnostic Pathology ·Zhuo Li, Weihua Li, Liyan Xue	4
5	A liquid biopsy signature predicts lymph node metastases in T1 oesophageal squamous cell carcinoma: implications for precision treatment strategy 2022 ·British Journal of Cancer ·Liyan Xue, Zitong Zhao, Minjie Wang, (unknown), (unknown), Shaoming Wang, Xuemin Xue, (unknown), Bingzhi Wang, Zhuo Li, Zhaoyang Yang, (unknown), Qimin Zhan, Yongmei Song	7
6	1207P Neoadjuvant PD-L1 inhibitor (socazolimab) plus chemotherapy in patients with locally advanced esophageal squamous cell carcinoma (ESCC): A multicenter, randomized, double-blind phase II study 2022 ·Annals of Oncology ·(unknown), Aiping Zhou, (unknown), (unknown), (unknown), (unknown), Hao Chen, (unknown), Yiqi Yu, (unknown), Liyan Xue, (unknown), Fenglong Bie, Bo Zhou, (unknown), Yiping Fang, (unknown), Xiangrong Dai, Shugeng Gao, Jian He	2
7	The efficacy of additional surgical resection after endoscopic resection in pT1b esophageal squamous cell carcinoma: A multi-institutional retrospective study in China 2022 ·Surgical Endoscopy ·Xuemin Xue, Qi Sun, Dongxian Jiang, Xinran Wang, Yong Liu, (unknown), (unknown), Na Cheng, Guiqi Wang, Yueping Liu, Yingyong Hou, Xiangshan Fan, Liyan Xue	1
8	CT diagnosis of pleural and stromal invasion in malignant subpleural pure ground-glass nodules: an exploratory study 2018 ·European Radiology ·Qing Zhao, Jianwei Wang, Lin Yang, Liyan Xue, Wenwen Lu	36
9	Piccolo mediates EGFR signaling and acts as a prognostic biomarker in esophageal squamous cell carcinoma 2017 ·Oncogene ·(unknown), Ruoxi Hong, Liyan Xue, (unknown), Xiaofang Liu, Ziran Zhao, (unknown), Dezuo Dong, Liwei Dong, (unknown), Liying Ma, Ning Lü, (unknown), Yongmei Song, Qimin Zhan	28
10	Genome wide copy number analyses of superficial esophageal squamous cell carcinoma with and without metastasis 2016 ·Oncotarget ·(unknown), Ling Shan, Liyan Xue, Bo Zheng, Jianming Ying, Ning Lü	10
11	Proteomics-based identification of tumor relevant proteins in lung adenocarcinoma 2013 ·Biomedicine & Pharmacotherapy ·Xin Zhou, Liyan Xue, Lihong Hao, Shuqing Liu, (unknown), Hai Xiong, Xiaoyu Qi, Dongmei Lin, Shujuan Shao	9
12	Overexpression of the DEC1 Protein Induces Senescence In Vitro and Is Related to Better Survival in Esophageal Squamous Cell Carcinoma 2012 ·PLoS ONE ·Qing Xu, Peiqing Ma, Chenfei Hu, Lechuang Chen, Liyan Xue, Zaozao Wang, Mei Liu, Hongxia Zhu, Ningzhi Xu, Ning Lü	33
13	[Comparison of histopathologic changes and expression of biomarkers in breast carcinoma before and after neoadjuvant chemotherapy]. 2011 ·PubMed ·Shan Zheng, (unknown), Ting Xiao, Shuangmei Zou, Liyan Xue, Wei Luo, Lei Guo, Xiuyun Liu, Ning Lü	5
14	Expressions of the gamma2 chain of laminin-5 and secreted protein acidic and rich in cysteine in esophageal squamous cell carcinoma and their relation to prognosis 2011 ·Chinese Journal of Cancer ·Liyan Xue, Shuangmei Zou, Shan Zheng, Xiuyun Liu, Wen Peng, (unknown), Dongmei Lin, Ning Lü	17
15	Distinct Genomic Alterations in Prostate Cancers in Chinese and Western Populations Suggest Alternative Pathways of Prostate Carcinogenesis 2010 ·Cancer Research ·Xueying Mao, Yongwei Yu, Lara K. Boyd, Guoping Ren, Dongmei Lin, Tracy Chaplin, Sakunthala C. Kudahetti, Elzbieta Stankiewicz, Liyan Xue, Luis Beltrán, Manu Gupta, R.T.D. Oliver, Nicholas R. Lemoine, Daniel M. Berney, Bryan D. Young, Yong‐Jie Lu	126
16	The Association of CCND1 Overexpression and Cisplatin Resistance in Testicular Germ Cell Tumors and Other Cancers 2010 ·American Journal Of Pathology ·Elodie Noël, Marc Yeste‐Velasco, Xueying Mao, (unknown), Sakunthala C. Kudahetti, Ningfeng Fiona Li, Swee Y. Sharp, Tracy Chaplin, Liyan Xue, Alan McIntyre, Ling Shan, Thomas Powles, R.T.D. Oliver, Bryan D. Young, Janet Shipley, Daniel M. Berney, Simon P. Joel, Yong‐Jie Lu	86
17	Tissue microarray analysis reveals a tight correlation between protein expression pattern and progression of esophageal squamous cell carcinoma 2006 ·BMC Cancer ·Liyan Xue, Nan Hu, Yongmei Song, Shuangmei Zou, Jianzhong Shou, (unknown), Liqun Ren, Dongmei Lin, Tong Tong, (unknown), Qimin Zhan, Philip R. Taylor, Ning Lü	54
18	Reduced MTA1 Expression by RNAi Inhibits in Vitro Invasion and Migration of Esophageal Squamous Cell Carcinoma Cell Line 2005 ·Clinical & Experimental Metastasis ·Haili Qian, Ning Lü, Liyan Xue, Xiao Liang, Xueyan Zhang, Ming Fu, Yongqiang Xie, Qimin Zhan, Zhihua Liu, (unknown)	45
19	Overexpression of human pituitary tumor transforming gene (hPTTG), is regulated by ?-catenin /TCF pathway in human esophageal squamous cell carcinoma 2004 ·International Journal of Cancer ·Cuiqi Zhou, Shuang Liu, Xiaobo Zhou, Liyan Xue, Lanping Quan, Ning Lü, Guo Zhang, Jinfeng Bai, Yihua Wang, Zhihua Liu, Qimin Zhan, Hongxia Zhu, Ningzhi Xu	64
20	Immunotherapy of Human Ovarian Carcinoma with OVAREX ^TM MAb-B43.13 in a Human-PBL-SCID/BG Mouse Model 1999 ·Hybridoma ·Birgit C. Schultes, Chengsheng Zhang, Liyan Xue, A.A. Noujaim, Ragupathy Madiyalakan	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact